Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens. How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibiotic-associated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“pathogen burden is reduced upon infection of mice monocolonized with a sialidase-deficient B. thetaiothaomicron strain [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“In mono-associated gnotobiotic mice, B. thetaiothaomicron-liberated sialic acid can support the expansion of pathogens such as C. difficile or S. enterica upon oral infection.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“In conventional mice, antibiotics reduce the amount of commensals competing for sugars liberated prior to treatment, increasing nutrient availability and favoring pathogen expansion througha limited time-window (peaking at day 1 and ending at day 3 post-antibiotic treatment for this study) [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
In the citing paper
“B. thetaiotaomicron also carries sialidases that can cleave sialic acid from mucus, although the bacterium lacks the enzymatic machinery necessary to catabolize such sugar [78].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Self-citationDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context
Lozupone, C., Hamady, M., & Knight, R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-371 · Cited by 1,453
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Research works printed but not linked: 3
- Martens EC Chiang HC Gordon JI Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont Cell host & microbe 2008 4 447 457 18996345 PMC2605320
- Chen X A mouse model of Clostridium difficile-associated disease Gastroenterology 2008 135 6 1984 1992 18848941
- Sonnenburg JL Glycan foraging in vivo by an intestine-adapted bacterial symbiont Science 2005 307 5717 1955 1959 15790854
Cited by
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
“Alteration of nutrient availability by thehostmicrobiota canalsohaveprofound consequences on the expression of virulence genes and growth rateof pathogenssuchasenterohemorragicE. coliorClostridium difficile (Kamada et al., 2013; Ng et al., 2013; Pacheco et al., 2012).”
BackgroundIntroduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Dysbiosis and the immune system
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.7 · Cited by 1,769
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“Pathogens, as well as usage of antibiotics, might disturb the intestinal mucus layer, either by enhancing mucus degradation, or by inhibiting the normal commensal triggers for mucus production [86].”
BackgroundGut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
“difficile, used a common strategy of cataboliz ing microbiota-liberated mucosal sugars, such as fucose and sialic acid, during their expansion within the gut (45).”
BackgroundInteractions between the microbiota and pathogenic bacteria in the gut
Bäumler, A. J., & Sperandio, V. (2016) · Nature · doi:10.1038/nature18849 · Cited by 1,420
The composition of the gut microbiota throughout life, with an emphasis on early life
Rodríguez, J. M., Murphy, K., Stanton, C., Ross, R. P., Kober, O. I., Juge, N., Avershina, E., Rudi, K., Narbad, A., Jenmalm, M. C., et al. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26050 · Cited by 1,318
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214
Core microbiomes for sustainable agroecosystems
Toju, H., Peay, K. G., Yamamichi, M., Narisawa, K., Hiruma, K., Naito, K., Fukuda, S., Ushio, M., Nakaoka, S., Onoda, Y., et al. (2018) · Nature Plants · doi:10.1038/s41477-018-0139-4 · Cited by 1,077
The Intestinal Microbiome in Early Life: Health and Disease
Arrieta, M.-C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M., & Finlay, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00427 · Cited by 1,024
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974
Langdon, A., Crook, N., & Dantas, G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0294-z · Cited by 912
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“commensals competing for sugars liberated before treatment, increasing nutrient availability and favoring pathogen expansion through a limited time-window (peaking at day 1 and ending at day 3 after antibiotic treatment for this study) [78].”
BackgroundMechanisms of inflammation-driven bacterial dysbiosis in the gut
Zeng, M. Y., Inohara, N., & Nuñez, G. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.75 · Cited by 877
Mucin glycan foraging in the human gut microbiome
Tailford, L. E., Crost, E. H., Kavanaugh, D., & Juge, N. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00081 · Cited by 839
Impact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Martens, E. C., Neumann, M., & Desai, M. S. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0036-x · Cited by 711
Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
Moya, A., & Ferrer, M. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.02.002 · Cited by 690
Gut Microbiota Promote Hematopoiesis to Control Bacterial Infection
Khosravi, A., Yáñez, A., Price, J. G., Chow, A., Merad, M., Goodridge, H. S., & Mazmanian, S. K. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.006 · Cited by 644
Antibiotics and the Gut Microbiota
Modi, S. R., Collins, J. J., & Relman, D. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72333 · Cited by 667
Antibiotics as deep modulators of gut microbiota: between good and evil
Ianiro, G., Tilg, H., & Gasbarrini, A. (2016) · Gut · doi:10.1136/gutjnl-2016-312297 · Cited by 625
Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
Lee, M., & Chang, E. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.056 · Cited by 645
An insider's perspective: Bacteroides as a window into the microbiome
Wexler, A. G., & Goodman, A. L. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.26 · Cited by 641
The evolution of cooperation within the gut microbiota
Rakoff-Nahoum, S., Foster, K. R., & Comstock, L. E. (2016) · Nature · doi:10.1038/nature17626 · Cited by 616
Charbonneau, M. R., O’Donnell, D., Blanton, L. V., Totten, S. M., Davis, J. C. C., Barratt, M. J., Cheng, J., Guruge, J., Talcott, M., Bain, J. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.024 · Cited by 606
“Therefore, it is important to consider that the presence of primary consumers of sialylated oligosaccharides maycreateopportunities for enteropathogens toachieveafitness benefit that could have deleterious effects on the host (Ng et al., 2013).”
BackgroundFate, activity, and impact of ingested bacteria within the human gut microbiota
Derrien, M., & van Hylckama Vlieg, J. E. T. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.03.002 · Cited by 605
Carbohydrate-active enzymes (CAZymes) in the gut microbiome
Wardman, J. F., Bains, R. K., Rahfeld, P., & Withers, S. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00712-1 · Cited by 597
Microbiome interactions shape host fitness
Gould, A. L., Zhang, V., Lamberti, L., Jones, E. W., Obadia, B., Korasidis, N., Gavryushkin, A., Carlson, J. M., Beerenwinkel, N., & Ludington, W. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809349115 · Cited by 579
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees
Raymann, K., Shaffer, Z., & Moran, N. A. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2001861 · Cited by 544
Cross-feeding in the gut microbiome: Ecology and mechanisms
Culp, E. J., & Goodman, A. L. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.016 · Cited by 504
Roles and regulation of the mucus barrier in the gut
Cornick, S., Tawiah, A., & Chadee, K. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.982426 · Cited by 526
Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness
Pickard, J. M., Maurice, C. F., Kinnebrew, M. A., Abt, M. C., Schenten, D., Golovkina, T. V., Bogatyrev, S. R., Ismagilov, R. F., Pamer, E. G., Turnbaugh, P. J., et al. (2014) · Nature · doi:10.1038/nature13823 · Cited by 535
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M. (2016) · Nature · doi:10.1038/nature20557 · Cited by 549
Fecal microbiota transplantation: in perspective
Gupta, S., Allen-Vercoe, E., & Petrof, E. O. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15607414 · Cited by 481
Brugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.-J., Ring, D., Diehl, M., Herp, S., Lötscher, Y., Hussain, S., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.215 · Cited by 476
Interactions of Intestinal Bacteria with Components of the Intestinal Mucus
Sicard, J.-F., Le Bihan, G., Vogeleer, P., Jacques, M., & Harel, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00387 · Cited by 458
Microbiota-mediated colonization resistance: mechanisms and regulation
Caballero-Flores, G., Pickard, J. M., & Núñez, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00833-7 · Cited by 474
Tracking heavy water (D 2 O) incorporation for identifying and sorting active microbial cells
Berry, D., Mader, E., Lee, T. K., Woebken, D., Wang, Y., Zhu, D., Palatinszky, M., Schintlmeister, A., Schmid, M. C., Hanson, B. T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420406112 · Cited by 455
Microbiome diversity protects against pathogens by nutrient blocking
Spragge, F., Bakkeren, E., Jahn, M. T., B. N. Araujo, E., Pearson, C. F., Wang, X., Pankhurst, L., Cunrath, O., & Foster, K. R. (2023) · Science · doi:10.1126/science.adj3502 · Cited by 435
Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile
Britton, R. A., & Young, V. B. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.059 · Cited by 446
Antibiotic perturbations to the gut microbiome
Fishbein, S. R. S., Mahmud, B., & Dantas, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00933-y · Cited by 440
“Most notably, treatment-induced disturbance of the gut community enables the growth of potentially infectious pathobi-onts (opportunistic microorganisms that proliferate on microbiome perturbation) with the capacity to cause disease 15,16 .”
BackgroundBifidobacterium longum subspecies infantis: champion colonizer of the infant gut
Underwood, M. A., German, J. B., Lebrilla, C. B., & Mills, D. A. (2015) · Pediatric Research · doi:10.1038/pr.2014.156 · Cited by 439
Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens
Pamer, E. G. (2016) · Science · doi:10.1126/science.aad9382 · Cited by 418
Quantitative imaging of gut microbiota spatial organization
Earle, K. A., Billings, G., Sigal, M., Lichtman, J. S., Hansson, G. C., Elias, J. E., Amieva, M. R., Huang, K. C., & Sonnenburg, J. L. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.002 · Cited by 433
“To examine this, we bicolonized mice with an avirulent strain of St (Stavir) , which eliminates the inflammatory effects caused by SPI-1and SPI-2-mediated invasion on localization, and with either wildtype Bt or the sialidasedeficient strain BtΔBT0455 (Ng et al., 2013).”
MethodSelf-citationThe native microbiome of the nematode Caenorhabditis elegans: gateway to a new host-microbiome model
Dirksen, P., Marsh, S. A., Braker, I., Heitland, N., Wagner, S., Nakad, R., Mader, S., Petersen, C., Kowallik, V., Rosenstiel, P., et al. (2016) · BMC Biology · doi:10.1186/s12915-016-0258-1 · Cited by 439
Role of priority effects in the early-life assembly of the gut microbiota
Sprockett, D., Fukami, T., & Relman, D. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.173 · Cited by 419
Narasimhan, S., Rajeevan, N., Liu, L., Zhao, Y. O., Heisig, J., Pan, J., Eppler-Epstein, R., DePonte, K., Fish, D., & Fikrig, E. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.001 · Cited by 400
Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications
Iredell, J., Brown, J., & Tagg, K. (2016) · BMJ · doi:10.1136/bmj.h6420 · Cited by 392
Recognizing Depression from the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., Hu, X., Wang, T., & Jin, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061592 · Cited by 380
Manipulation of the Quorum Sensing Signal AI-2 Affects the Antibiotic-Treated Gut Microbiota
Thompson, J. A., Oliveira, R. A., Djukovic, A., Ubeda, C., & Xavier, K. B. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.049 · Cited by 392
Microbial nutrient niches in the gut
Pereira, F. C., & Berry, D. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13659 · Cited by 369
Fecal microbiota transplantation: current challenges and future landscapes
Yadegar, A., Bar-Yoseph, H., Monaghan, T. M., Pakpour, S., Severino, A., Kuijper, E. J., Smits, W. K., Terveer, E. M., Neupane, S., Nabavi-Rad, A., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-22 · Cited by 351
Ternan, N. G., Moore, N. D., Smyth, D., McDougall, G. J., Allwood, J. W., Verrall, S., Gill, C. I. R., Dooley, J. S. G., & McMullan, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-35050-x · Cited by 377
Ferreyra, J. A., Wu, K. J., Hryckowian, A. J., Bouley, D. M., Weimer, B. C., & Sonnenburg, J. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.003 · Cited by 378
Self-citationMucosal immunity to pathogenic intestinal bacteria
Perez-Lopez, A., Behnsen, J., Nuccio, S.-P., & Raffatellu, M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.17 · Cited by 375
The role of the gut microbiota in sepsis
Haak, B. W., & Wiersinga, W. J. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30119-4 · Cited by 367
Looft, T., Allen, H. K., Cantarel, B. L., Levine, U. Y., Bayles, D. O., Alt, D. P., Henrissat, B., & Stanton, T. B. (2014) · The ISME Journal · doi:10.1038/ismej.2014.12 · Cited by 373
Malla, M. A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., & Abd_Allah, E. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02868 · Cited by 345
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.
Allegretti, J. R., Mullish, B. H., Kelly, C., & Fischer, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31266-8 · Cited by 358
Sassone-Corsi, M., & Raffatellu, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403169 · Cited by 328
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Guo, X. Y., Liu, X. J., & Hao, J. Y. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12849 · Cited by 336
Sorbara, M. T., & Pamer, E. G. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0053-0 · Cited by 320
Understanding Competition and Cooperation within the Mammalian Gut Microbiome
Coyte, K. Z., & Rakoff-Nahoum, S. (2019) · Current Biology · doi:10.1016/j.cub.2019.04.017 · Cited by 329
The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors
Lobionda, S., Sittipo, P., Kwon, H. Y., & Lee, Y. K. (2019) · Microorganisms · doi:10.3390/microorganisms7080271 · Cited by 317
Pham, T. A. N., Clare, S., Goulding, D., Arasteh, J. M., Stares, M. D., Browne, H. P., Keane, J. A., Page, A. J., Kumasaka, N., Kane, L., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.017 · Cited by 305
Microbiome therapeutics — Advances and challenges
Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317
Commensal and Pathogenic Escherichia coli Metabolism in the Gut
Conway, T., & Cohen, P. S. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0006-2014 · Cited by 303
Khanna, S., Pardi, D. S., Kelly, C. R., Kraft, C. S., Dhere, T., Henn, M. R., Lombardo, M.-J., Vulic, M., Ohsumi, T., Winkler, J., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv766 · Cited by 321
Mucispirillum schaedleri Antagonizes Salmonella Virulence to Protect Mice against Colitis
Herp, S., Brugiroux, S., Garzetti, D., Ring, D., Jochum, L. M., Beutler, M., Eberl, C., Hussain, S., Walter, S., Gerlach, R. G., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.03.004 · Cited by 318
Oxygen as a driver of gut dysbiosis
Rivera-Chávez, F., Lopez, C. A., & Bäumler, A. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.022 · Cited by 320
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile
Theriot, C. M., & Young, V. B. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104115 · Cited by 302
Pereira, F. C., Wasmund, K., Cobankovic, I., Jehmlich, N., Herbold, C. W., Lee, K. S., Sziranyi, B., Vesely, C., Decker, T., Stocker, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18928-1 · Cited by 317
Curtis, M. M., Hu, Z., Klimko, C., Narayanan, S., Deberardinis, R., & Sperandio, V. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.005 · Cited by 307
Antibiotic use and microbiome function
Ferrer, M., Méndez-García, C., Rojo, D., Barbas, C., & Moya, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.007 · Cited by 299
Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium
Caballero, S., Kim, S., Carter, R. A., Leiner, I. M., Sušac, B., Miller, L., Kim, G. J., Ling, L., & Pamer, E. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.002 · Cited by 308
Mining the microbiota for microbial and metabolite-based immunotherapies
Skelly, A. N., Sato, Y., Kearney, S., & Honda, K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0144-5 · Cited by 306
Action and function of Akkermansia muciniphila in microbiome ecology, health and disease
Ottman, N., Geerlings, S. Y., Aalvink, S., de Vos, W. M., & Belzer, C. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.10.001 · Cited by 289
Intestinal mucus and their glycans: A habitat for thriving microbiota
Luis, A. S., & Hansson, G. C. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.026 · Cited by 284
Bridging intestinal immunity and gut microbiota by metabolites
Wang, G., Huang, S., Wang, Y., Cai, S., Yu, H., Liu, H., Zeng, X., Zhang, G., & Qiao, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03190-6 · Cited by 293
Moon, C. D., Young, W., Maclean, P. H., Cookson, A. L., & Bermingham, E. N. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.677 · Cited by 272
Baxter, N. T., Zackular, J. P., Chen, G. Y., & Schloss, P. D. (2014) · Microbiome · doi:10.1186/2049-2618-2-20 · Cited by 299
“Additionally, previous studies have linked mucin degradation by Bacteroides and Akkermansia with intestinal inflammation [45-47].”
BackgroundEffects of Antibiotics on Human Microbiota and Subsequent Disease
Keeney, K. M., Yurist-Doutsch, S., Arrieta, M.-C., & Finlay, B. B. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091313-103456 · Cited by 291
Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies
Tramontano, M., Andrejev, S., Pruteanu, M., Klünemann, M., Kuhn, M., Galardini, M., Jouhten, P., Zelezniak, A., Zeller, G., Bork, P., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0123-9 · Cited by 295
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
“…sialic acid as their energy source depend on the presence and activity of B. thetaiotaomicron, as reported that B. thetaiotaomicron mutants that have no sialidase activity, are failed to give a growth advantage to these two pathogenic bacteria i.e. C. difficile and S. Typhimurium (Ng et al., 2013).”
BackgroundInfluentialZhong, W., Shahbaz, O., Teskey, G., Beever, A., Kachour, N., Venketaraman, V., & Darmani, N. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115797 · Cited by 253
Biochemistry of complex glycan depolymerisation by the human gut microbiota
Ndeh, D., & Gilbert, H. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy002 · Cited by 284
An integrative view of microbiome-host interactions in inflammatory bowel diseases
Wlodarska, M., Kostic, A. D., & Xavier, R. J. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.008 · Cited by 287
“However, pathogenic bacteria can take advantage of these liberated sugars to facilitate their expansion (Ng et al., 2013).”
BackgroundRegulation of the Immune System by the Resident Intestinal Bacteria
Kamada, N., & Núñez, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.060 · Cited by 269
Evolutionary and Ecological Consequences of Gut Microbial Communities
Moran, N. A., Ochman, H., & Hammer, T. J. (2019) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev-ecolsys-110617-062453 · Cited by 275
Preferential Packing of Acidic Glycosidases and Proteases into Bacteroides Outer Membrane Vesicles
Elhenawy, W., Debelyy, M. O., & Feldman, M. F. (2014) · mBio · doi:10.1128/mbio.00909-14 · Cited by 271
Finding alternatives to antibiotics
Allen, H. K., Trachsel, J., Looft, T., & Casey, T. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12468 · Cited by 269
Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth
Gillis, C. C., Hughes, E. R., Spiga, L., Winter, M. G., Zhu, W., Furtado de Carvalho, T., Chanin, R. B., Behrendt, C. L., Hooper, L. V., Santos, R. L., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.006 · Cited by 274
Metadata
- Authors
- Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., & Sonnenburg, J. L.
- Affiliations
- Stanford Medicine (US)
- Mayo Clinic (US)
- University of California San Diego (US)
- University of California, Davis (US)
- Corresponding author
- Sonnenburg, Justin L.
- ORCID
- Venue
- Nature
- Published
- 2013-09-01
- Volume
- 502
- Issue
- 7469
- Pages
- 96-99
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3825626
- OpenAlex
- W2026894676
- Cited by
- 1,035
- References
- 40
- Citations by year
- 2026: 57 · 2025: 75 · 2024: 93 · 2023: 61 · 2022: 81 · 2021: 74 · 2020: 90 · 2019: 59 · 2018: 89 · 2017: 91 · 2016: 84 · 2015: 78 · 2014: 95 · 2013: 8
- FWCI
- 39.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI089722, T32AI007328)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085025)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- gut microbiota, antibiotic-associated infection, enteric pathogens, Salmonella typhimurium, Clostridium difficile, sialic acid, Bacteroides thetaiotaomicron, neuraminidase, fucose, sialic acid catabolism, gnotobiotic mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Enterocolitis, Pseudomembranous, Female, Fucose, Intestinal Mucosa, Male, Neuraminidase, Salmonella Infections, Salmonella typhimurium, Specific Pathogen-Free Organisms, Gene Expression Regulation, Bacterial, Clostridioides difficile, N-Acetylneuraminic Acid, Gene Expression Profiling, Carbohydrate Metabolism, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.